Top

Published in:

01-04-2013 | Letter

Plasma tau levels in Alzheimer's disease

Authors: Henrik Zetterberg, David Wilson, Ulf Andreasson, Lennart Minthon, Kaj Blennow, Jeffrey Randall, Oskar Hansson

Published in: Alzheimer's Research & Therapy | Issue 2/2013

Excerpt

Efforts to find reliable blood biomarkers for Alzheimer's disease (AD) in a highly warranted clinical laboratory test have met with little success. There is no clear change in plasma β-amyloid in AD, and assays for the axonal injury marker tau have been hampered by a lack of analytical sensitivity for accurate measurement in blood samples [1]. Here, the results of a novel ultra-sensitive assay for tau in peripheral blood are reported. …

Available only for authorised users

Blennow K, Hampel H, Weiner M, Zetterberg H: Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010, 6: 131-144. 10.1038/nrneurol.2010.4.CrossRefPubMed

Randall J, Mörtberg E, Provuncher GK, Fournier DR, Duffy DC, Rubertsson S, Blennow K, Zetterberg H, Wilson DH: Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study. Resuscitation. 2012, Aug 9,

Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L, Piech T, Patel PP, Chang L, Rivnak AJ, Ferrell EP, Randall JD, Provuncher GK, Walt DR, Duffy DC: Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol. 2010, 28: 595-599. 10.1038/nbt.1641.PubMedCentralCrossRefPubMed

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984, 34: 939-944. 10.1212/WNL.34.7.939.CrossRefPubMed

Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004, 256: 240-246. 10.1111/j.1365-2796.2004.01380.x.CrossRefPubMed

Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, Blennow K: Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett. 2001, 297: 187-190. 10.1016/S0304-3940(00)01697-9.CrossRefPubMed

Title: Plasma tau levels in Alzheimer's disease
Authors: Henrik Zetterberg
David Wilson
Ulf Andreasson
Lennart Minthon
Kaj Blennow
Jeffrey Randall
Oskar Hansson
Publication date: 01-04-2013
Publisher: BioMed Central
Published in: Alzheimer's Research & Therapy / Issue 2/2013
Electronic ISSN: 1758-9193
DOI: https://doi.org/10.1186/alzrt163

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Plasma tau levels in Alzheimer's disease

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2013

Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker

Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models

Have we learnt all we need to know from genetic studies - is genetics over in Alzheimer's disease?

Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model